Advertisement
New Zealand markets closed
  • NZX 50

    12,809.00
    +40.46 (+0.32%)
     
  • NZD/USD

    0.6063
    +0.0003 (+0.05%)
     
  • NZD/EUR

    0.5589
    -0.0001 (-0.01%)
     
  • ALL ORDS

    8,536.00
    -88.10 (-1.02%)
     
  • ASX 200

    8,266.90
    -89.00 (-1.07%)
     
  • OIL

    70.84
    +0.17 (+0.24%)
     
  • GOLD

    2,725.80
    +18.30 (+0.68%)
     
  • NASDAQ

    20,190.42
    +16.38 (+0.08%)
     
  • FTSE

    8,385.13
    +56.06 (+0.67%)
     
  • Dow Jones

    43,239.05
    +161.35 (+0.37%)
     
  • DAX

    19,583.39
    +150.58 (+0.77%)
     
  • Hang Seng

    20,221.70
    +142.60 (+0.71%)
     
  • NIKKEI 225

    38,925.66
    +14.47 (+0.04%)
     
  • NZD/JPY

    90.8410
    -0.1190 (-0.13%)
     

Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug

Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug

Biogen stock tumbled Friday after European regulators rejected its Eisai-partnered Alzheimer's treatment, citing steep side effects.